DOCSLIB.ORG

Subunit-Selective Iglur Antagonists Can Potentiate Heteromeric Receptor Responses by Blocking Desensitization

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Subunit-Selective Iglur Antagonists Can Potentiate Heteromeric Receptor Responses by Blocking Desensitization Subunit-selective iGluR antagonists can potentiate heteromeric receptor responses by blocking desensitization Stefan Polloka and Andreas Reinera,1 aDepartment of Biology and Biotechnology, Ruhr University Bochum, 44801 Bochum, Germany Edited by Ehud Y. Isacoff, University of California, Berkeley, CA, and approved August 31, 2020 (received for review April 18, 2020) Ionotropic glutamate receptors (iGluRs) are key molecules for treating pain (LY5454694) (17). In the case of AMPA receptors, synaptic signaling in the central nervous system, which makes which have more closely related ligand-binding domains (LBDs), them promising drug targets. Intensive efforts are being devoted some moderately selective agonists have been reported, but to the development of subunit-selective ligands, which should en- subunit-selective antagonists are rare (18). able more precise pharmacologic interventions while limiting the Subunit-specific ligands are thought to allow for more precise effects on overall neuronal circuit function. However, many AMPA intervention, as their action remains confined to a small set of and kainate receptor complexes in vivo are heteromers composed receptor subtypes and to the brain regions where these subtypes of different subunits. Despite their importance, little is known are expressed. However, many or even most neuronal iGluRs are about how subunit-selective ligands affect the gating of hetero- heteromeric receptors (3, 4, 19–23), which increases the versa- meric iGluRs, namely their activation and desensitization proper- – ties. Using fast ligand application experiments, we studied the tility of iGluR signaling (24 26) and allows for fine-tuned reg- effects of competitive antagonists that block glutamate from bind- ulation. This motivated us to investigate how heteromeric kainate ing at part of the four subunits. We found that UBP-310, a kainate and AMPA receptors are impacted by subunit-specific ligands. receptor antagonist with high selectivity for GluK1 subunits, re- One hallmark of AMPA and kainate receptor gating is their duces the desensitization of GluK1/GluK2 heteromers and fully fast (millisecond) desensitization, which is induced by prolonged abolishes the desensitization of GluK1/GluK5 heteromers. This ef- glutamate binding. Desensitization is tightly regulated by, for ex- PHARMACOLOGY fect is mirrored by subunit-selective agonists and heteromeric re- ample, RNA splicing (27) and auxiliary subunits (28–31). Depend- ceptors that contain binding-impaired subunits, as we show for ing on the glutamate dynamics in the synaptic cleft, desensitization both kainate and GluA2 AMPA receptors. These findings are con- exerts important physiological functions. It can terminate the cur- sistent with a model in which incomplete agonist occupancy at the rent flow after glutamate release and can shape the responses to low four receptor subunits can provide activation without inducing residual concentrations of glutamate (e.g., refs. 32, 33). Recovery desensitization. However, we did not detect significant steady-state from desensitization is slow, taking tens of milliseconds in the case currents during UBP-310 dissociation from GluK1 homotetramers, in- of AMPA receptors but seconds for kainate receptors (34). De- dicating that antagonist dissociation proceeds in a nonuniform and sensitization and recovery may thus control the responses to sub- cooperativity-driven manner, which disfavors nondesensitizing occu- pancy states. Besides providing mechanistic insights, these results sequent release events and may affect postsynaptic short-term have direct implications for the use of subunit-selective antagonists plasticity and frequency dependence (29). Suppression of AMPA in neuroscience research and envisioned therapeutic interventions. receptor desensitization causes severe developmental defects (35). ligand-gated ion channel | medicinal chemistry | non-NMDA receptor | Significance receptor modulation Ionotropic glutamate receptors (iGluRs) are a diverse family of lutamate is an important neurotransmitter in the mamma- tetrameric ligand-gated ion channels. Recent structural infor- Glian brain. Its excitatory action is mediated by ionotropic mation has provided valuable insight into the conformational glutamate receptors (iGluRs), a family of tetrameric ligand-gated dynamics and assembly properties of iGluRs, most importantly ion channels comprising 18 different genes (1, 2). The different on heteromeric iGluRs, which are prevalent in the nervous iGluR subtypes play key roles in synaptic transmission, modula- system. However, little is known about how channel gating is tion, and plasticity (3–5); thus, controlling iGluR function may be controlled by the 4 subunits within the tetramers, different li- useful for treating a wide range of diseases, such as pain, migraine, gand occupancies, and intersubunit cooperativity. In this study, epilepsy, mood disorders, and addiction, as well as for managing we probe how subunit-selective ligands affect activation and desensitization of heteromeric iGluRs and we provide mecha- ischemic stroke, glioblastoma, and neurodegeneration. nistic insight into ligand dissociation. Our findings have direct The discovery of agonists and antagonists that discriminate pharmacologic implications, as we show that subunit-selective between the AMPA (GluA), kainate (GluK), and NMDA (GluN) antagonists can block desensitization of heteromeric iGluRs, receptor subfamilies (1, 6) was a key step in dissecting their thereby causing potentiation instead of inhibition. physiological functions. However, the clinical utility of iGluR ag- onists and antagonists has remained limited, because broad acti- Author contributions: S.P. and A.R. designed research; S.P. performed research; S.P. and vation or inhibition of iGluRs is associated with severe side effects A.R. analyzed data; and S.P. and A.R. wrote the paper. (e.g., refs. 7–9). To overcome these side effects, current medicinal The authors declare no competing interest. research is focusing on allosteric ligands with modulatory effects This article is a PNAS Direct Submission. and subunit-specific ligands that show selective binding at only one Published under the PNAS license. or a few iGluR subtypes (10–12). For instance, subunit-selective 1To whom correspondence may be addressed. Email: [email protected]. kainate receptor antagonists have been proposed for treating ce- This article contains supporting information online at https://www.pnas.org/lookup/suppl/ rebral ischemia (LY377770) (13), anxiety (LY382884) (14), and doi:10.1073/pnas.2007471117/-/DCSupplemental. epilepsy (UBP-310) (15, 16) and have been in clinical trials for www.pnas.org/cgi/doi/10.1073/pnas.2007471117 PNAS Latest Articles | 1of8 Downloaded by guest on September 29, 2021 Recent full-length iGluR structures provide insight into the which became part of some widely used models to describe iGluR conformational changes occurring on ligand binding (36–39), but gating (26, 47). However, the interpretation of experiments with how the ligand occupancy at the four LBDs controls receptor low ligand concentrations is complicated by slow binding kinetics activation and desensitization remains unclear. Structure-function and the fact that mid- and high-occupancy states are still sampled studies have revealed that glutamate binding leads to closure of occasionally (48). the clamshell-like LBDs, which appears to be a requirement for More recent work on a special class of heteromeric kainate efficient activation (40). Single-channel recordings on desensitization- receptors—those incorporating both low- and high-affinity sub- blocked receptors have demonstrated that at least two subunits must units (e.g., GluK2 and GluK5, respectively; formerly known as be occupied by agonists for substantial activation to occur (31, 41). GluR6 and KA2)—has shown that these receptors can evade Desensitization is thought to originate from rearrangements of the desensitization with two occupied subunits while showing sub- interface between two adjacent LBDs, as stabilization of this interface stantial activation (48–50). In these experiments, subunit-selective can slow or abolish desensitization (42–45). agonists (48, 51), the incorporation of mutated subunits with Based on the observation that even low glutamate concen- lowered affinity (49, 50), and tethered photoswitchable ligands trations elicit efficient desensitization in the absence of significant (48) were used to ensure less than full receptor occupancy. activation (31, 46, 47), it was further concluded that a single oc- However, whether this behavior also applies to other types of cupied subunit may be sufficient to cause receptor desensitization, kainate receptors and the postsynaptically far more abundant A 4 3:1 2:2 1:3 4 GluK1 GluK1/GluK2 heteromers GluK2 B GluK1 GluK1/GluK2 GluK2 1 μM UBP-310 10 μM UBP-310 10 μM UBP-310 3 mM Glu 3 mM Glu 3 mM Glu Iss / Ipeak= 1.2 % Iss / Ipeak= 26 % τdes= 0.7 ms τdes= 2.1 ms τdes= 3.9 ms τdes= 3.2 ms τdes= 3.0 ms A UPB / A Glu= 0.23 25 pA 50 pA 25 pA 5 ms 20 ms 5 ms C K1 K1/2 K2 DFK1 K1/2 K2 E K1 K1/2 K2 K1/2 10 μM UBP-310 (7) (17) (8) (7) (17) (8) (7) (17) (8) (37)(17) 1.2 *** *** ns *** ns ** ns 80 1.0 30 6 60 0.8 (%) (%) 20 4 (rel.) 0.6 (ms) 40 peak peak I I / des / peak τ I ss 0.4 ss I I 10 pA 10 2 20 0.2 20 ms 0 0 0 0 +++ - + - + - + - + - + - + + UBP UBP UBP UBP Fig. 1. Effects of UBP-310, a GluK1-selective antagonist, on GluK1/GluK2 heteromers. (A) Cartoon representation of GluK1/GluK2 receptors with variable
Load more

Recommended publications
  • A Guide to Glutamate Receptors
    A guide to glutamate receptors 1 Contents Glutamate receptors . 4 Ionotropic glutamate receptors . 4 - Structure ........................................................................................................... 4 - Function ............................................................................................................ 5 - AMPA receptors ................................................................................................. 6 - NMDA receptors ................................................................................................. 6 - Kainate receptors ............................................................................................... 6 Metabotropic glutamate receptors . 8 - Structure ........................................................................................................... 8 - Function ............................................................................................................ 9 - Group I: mGlu1 and mGlu5. .9 - Group II: mGlu2 and mGlu3 ................................................................................. 10 - Group III: mGlu4, mGlu6, mGlu7 and mGlu8 ............................................................ 10 Protocols and webinars . 11 - Protocols ......................................................................................................... 11 - Webinars ......................................................................................................... 12 References and further reading . 13 Excitatory synapse pathway
    [Show full text]
  • Glycine Activated Ion Channel Subunits Encoded by Ctenophore
    Glycine activated ion channel subunits encoded by PNAS PLUS ctenophore glutamate receptor genes Robert Albersteina, Richard Greya, Austin Zimmeta, David K. Simmonsb, and Mark L. Mayera,1 aLaboratory of Cellular and Molecular Neurophysiology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892; and bThe Whitney Laboratory for Marine Bioscience, University of Florida, St. Augustine, FL 32080 Edited by Christopher Miller, Howard Hughes Medical Institute, Brandeis University, Waltham, MA, and approved September 2, 2015 (received for review July 13, 2015) Recent genome projects for ctenophores have revealed the subunits and glutamate to GluN2 subunits for activation of ion presence of numerous ionotropic glutamate receptors (iGluRs) in channel gating (12, 14–17), as well as depolarization to relieve + Mnemiopsis leidyi and Pleurobrachia bachei, among our earliest ion channel block by extracellular Mg2 (18, 19). The initial metazoan ancestors. Sequence alignments and phylogenetic analy- annotation of the M. leidyi genome identified 16 candidate iGluR sis show that these form a distinct clade from the well-characterized genes (4), whereas in the draft genome of P. bachei, 14 iGluRs AMPA, kainate, and NMDA iGluR subtypes found in vertebrates. were annotated as kainate-like receptors (5). In view of growing Although annotated as glutamate and kainate receptors, crystal interest in the molecular evolution of ion channels and receptors, structures of the ML032222a and PbiGluR3 ligand-binding domains and the pivotal role that ctenophores play in our current un- (LBDs) reveal endogenous glycine in the binding pocket, whereas derstanding of nervous system development (20), we initiated a ligand-binding assays show that glycine binds with nanomolar af- structural and functional characterization of glutamate receptors finity; biochemical assays and structural analysis establish that glu- expressed in both species.
    [Show full text]
  • Characterization of a Domoic Acid Binding Site from Pacific Razor Clam
    Aquatic Toxicology 69 (2004) 125–132 Characterization of a domoic acid binding site from Pacific razor clam Vera L. Trainer∗, Brian D. Bill NOAA Fisheries, Northwest Fisheries Science Center, Marine Biotoxin Program, 2725 Montlake Blvd. E., Seattle, WA 98112, USA Received 5 November 2003; received in revised form 27 April 2004; accepted 27 April 2004 Abstract The Pacific razor clam, Siliqua patula, is known to retain domoic acid, a water-soluble glutamate receptor agonist produced by diatoms of the genus Pseudo-nitzschia. The mechanism by which razor clams tolerate high levels of the toxin, domoic acid, in their tissues while still retaining normal nerve function is unknown. In our study, a domoic acid binding site was solubilized from razor clam siphon using a combination of Triton X-100 and digitonin. In a Scatchard analysis using [3H]kainic acid, the partially-purified membrane showed two distinct receptor sites, a high affinity, low capacity site with a KD (mean ± S.E.) of 28 ± 9.4 nM and a maximal binding capacity of 12 ± 3.8 pmol/mg protein and a low affinity, high capacity site with a mM affinity for radiolabeled kainic acid, the latter site which was lost upon solubilization. Competition experiments showed that the rank order potency for competitive ligands in displacing [3H]kainate binding from the membrane-bound receptors was quisqualate > ibotenate > iodowillardiine = AMPA = fluorowillardiine > domoate > kainate > l-glutamate. At high micromolar concentrations, NBQX, NMDA and ATPA showed little or no ability to displace [3H]kainate. In contrast, Scatchard analysis 3 using [ H]glutamate showed linearity, indicating the presence of a single binding site with a KD and Bmax of 500 ± 50 nM and 14 ± 0.8 pmol/mg protein, respectively.
    [Show full text]
  • Advances in the Synthesis of 5- and 6-Substituted Uracil Derivatives
    701xml UOPP_A_438055 October 9, 2009 12:27 UOPP #438055, VOL 41, ISS 6 Advances in the Synthesis of 5- and 6-Substituted Uracil Derivatives Javier I. Bardag´ı and Roberto A. Rossi QUERY SHEET This page lists questions we have about your paper. The numbers displayed at left can be found in the text of the paper for reference. In addition, please review your paper as a whole for correctness. There are no Editor Queries for this paper. TABLE OF CONTENTS LISTING The table of contents for the journal will list your paper exactly as it appears below: Advances in the Synthesis of 5- and 6-Substituted Uracil Derivatives Javier I. Bardag´ı and Roberto A. Rossi 701xml UOPP_A_438055 October 9, 2009 12:27 Organic Preparations and Procedures International, 41:1–36, 2009 Copyright © Taylor & Francis Group, LLC ISSN: 0030-4948 print DOI: 10.1080/00304940903378776 Advances in the Synthesis of 5- and 6-Substituted Uracil Derivatives Javier I. Bardag´ı and Roberto A. Rossi INFIQC, Departamento de Qu´ımica Organica,´ Facultad de Ciencias Qu´ımicas, Universidad Nacional de Cordoba,´ Ciudad Universitaria, 5000 Cordoba,´ ARGENTINA INTRODUCTION ................................................................................... 2 I. Uracils with Carbon-based Substituent ................................................. 3 1. C(Uracil)-C(sp3) Bonds............................................................................ 3 a. Perfluoroalkyl Compounds...................................................................12 2. C(Uracil)-C(sp2) Bonds...........................................................................13
    [Show full text]
  • Interplay Between Gating and Block of Ligand-Gated Ion Channels
    brain sciences Review Interplay between Gating and Block of Ligand-Gated Ion Channels Matthew B. Phillips 1,2, Aparna Nigam 1 and Jon W. Johnson 1,2,* 1 Department of Neuroscience, University of Pittsburgh, Pittsburgh, PA 15260, USA; [email protected] (M.B.P.); [email protected] (A.N.) 2 Center for Neuroscience, University of Pittsburgh, Pittsburgh, PA 15260, USA * Correspondence: [email protected]; Tel.: +1-(412)-624-4295 Received: 27 October 2020; Accepted: 26 November 2020; Published: 1 December 2020 Abstract: Drugs that inhibit ion channel function by binding in the channel and preventing current flow, known as channel blockers, can be used as powerful tools for analysis of channel properties. Channel blockers are used to probe both the sophisticated structure and basic biophysical properties of ion channels. Gating, the mechanism that controls the opening and closing of ion channels, can be profoundly influenced by channel blocking drugs. Channel block and gating are reciprocally connected; gating controls access of channel blockers to their binding sites, and channel-blocking drugs can have profound and diverse effects on the rates of gating transitions and on the stability of channel open and closed states. This review synthesizes knowledge of the inherent intertwining of block and gating of excitatory ligand-gated ion channels, with a focus on the utility of channel blockers as analytic probes of ionotropic glutamate receptor channel function. Keywords: ligand-gated ion channel; channel block; channel gating; nicotinic acetylcholine receptor; ionotropic glutamate receptor; AMPA receptor; kainate receptor; NMDA receptor 1. Introduction Neuronal information processing depends on the distribution and properties of the ion channels found in neuronal membranes.
    [Show full text]
  • Cellular Trafficking of Nicotinic Acetylcholine Receptors
    npg Acta Pharmacol Sin 2009 Jun; 30 (6): 656–662 Review Cellular trafficking of nicotinic acetylcholine receptors Paul A ST JOHN* Department of Cell Biology and Anatomy, University of Arizona College of Medicine, Tucson, AZ 85724, USA Nicotinic acetylcholine receptors (nAChRs) play critical roles throughout the body. Precise regulation of the cellular loca- tion and availability of nAChRs on neurons and target cells is critical to their proper function. Dynamic, post-translational regulation of nAChRs, particularly control of their movements among the different compartments of cells, is an important aspect of that regulation. A combination of new information and new techniques has the study of nAChR trafficking poised for new breakthroughs. Keywords: membrane traffic; protein traffic; biosynthesis; endocytosis; endoplasmic reticulum-associated degradation Acta Pharmacologica Sinica (2009) 30: 656–662; doi: 10.1038/aps.2009.76 Introduction ways, but two particular perturbations have been especially well studied and exert their effects at least in part by altering Nicotinic acetylcholine receptors (nAChRs) mediate the trafficking of nAChRs: 1) denervation changes the total synaptic transmission in the CNS, in autonomic ganglia, and number, the distribution, and the turnover rate of nAChRs in at neuromuscular junctions and other peripheral synapses. skeletal muscle; 2) prolonged exposure to nicotine increases The functional properties of these synapses differ, but in each the total number of nAChRs in neurons. Several of the stud- case, properly functional signaling requires cellular control ies reviewed here addressed the mechanisms by which these of the number, type, and location of nAChRs. Trafficking treatments alter nAChR trafficking. Other authors in this of nAChRs – the movement of nAChRs between compart- special issue will address other aspects of the effects of nico- ments of a cell, including the cell's biosynthetic and degrada- tine on nAChRs.
    [Show full text]
  • Kainate Receptors Depress Excitatory Synaptic Transmission at CA33CA1 Synapses in the Hippocampus Via a Direct Presynaptic Action
    The Journal of Neuroscience, May 1, 2001, 21(9):2958–2966 Kainate Receptors Depress Excitatory Synaptic Transmission at CA33CA1 Synapses in the Hippocampus via a Direct Presynaptic Action Matthew Frerking,1 Dietmar Schmitz,1 Qiang Zhou,1 Joshua Johansen,2 and Roger A. Nicoll1,2 Departments of 1Cellular and Molecular Pharmacology and 2Physiology, University of California, San Francisco, California 94143-0450 Kainate receptor activation depresses synaptic release of neu- excitation and subsequent release of a neuromodulator. Pre- rotransmitter at a number of synapses in the CNS. The mech- synaptic depolarization, achieved via increasing extracellular anism underlying this depression is controversial, and both K ϩ, caused a depression of the presynaptic fiber volley and an ionotropic and metabotropic mechanisms have been sug- increase in the frequency of miniature EPSCs. Neither effect gested. We report here that the AMPA/kainate receptor ago- was observed with DA, suggesting that DA does not depress nists domoate (DA) and kainate (KA) cause a presynaptic de- transmission via a presynaptic depolarization. However, the pression of glutamatergic transmission at CA33CA1 synapses effects of DA were abolished by the G-protein inhibitors in the hippocampus, which is not blocked by the AMPA recep- N-ethylmaleimide and pertussis toxin. These results suggest tor antagonist GYKI 53655 but is blocked by the AMPA/KA that KA receptor activation depresses synaptic transmission at receptor antagonist CNQX. Neither a blockade of interneuronal this synapse via a direct, presynaptic, metabotropic action. discharge nor antagonists of several neuromodulators affect Key words: domoate; kainate; metabotropic; presynaptic; the depression, suggesting that it is not the result of indirect hippocampus; CA1 Neurotransmitter receptors in the CNS can be separated into two use-dependent depression.
    [Show full text]
  • A Human Stem Cell-Derived Test System for Agents Modifying Neuronal N
    Archives of Toxicology (2021) 95:1703–1722 https://doi.org/10.1007/s00204-021-03024-0 IN VITRO SYSTEMS A human stem cell‑derived test system for agents modifying neuronal 2+ N‑methyl‑D‑aspartate‑type glutamate receptor Ca ‑signalling Stefanie Klima1,2 · Markus Brüll1 · Anna‑Sophie Spreng1,3 · Ilinca Suciu1,3 · Tjalda Falt1 · Jens C. Schwamborn4 · Tanja Waldmann1 · Christiaan Karreman1 · Marcel Leist1,5 Received: 28 October 2020 / Accepted: 4 March 2021 / Published online: 13 March 2021 © The Author(s) 2021 Abstract Methods to assess neuronal receptor functions are needed in toxicology and for drug development. Human-based test systems that allow studies on glutamate signalling are still scarce. To address this issue, we developed and characterized pluripotent stem cell (PSC)-based neural cultures capable of forming a functional network. Starting from a stably proliferating neu- roepithelial stem cell (NESC) population, we generate “mixed cortical cultures” (MCC) within 24 days. Characterization by immunocytochemistry, gene expression profling and functional tests (multi-electrode arrays) showed that MCC contain various functional neurotransmitter receptors, and in particular, the N-methyl-D-aspartate subtype of ionotropic glutamate receptors (NMDA-R). As this important receptor is found neither on conventional neural cell lines nor on most stem cell- derived neurons, we focused here on the characterization of rapid glutamate-triggered Ca2+ signalling. Changes of the intra- 2+ cellular free calcium ion concentration ([Ca ]i) were measured by fuorescent imaging as the main endpoint, and a method to evaluate and quantify signals in hundreds of cells at the same time was developed. We observed responses to glutamate in the low µM range.
    [Show full text]
  • L-Proline and Glutamatergic Neurotransmission: Clarifying The
    L-Proline and Glutamatergic Neurotransmission: Clarifying the Modulatory Role of Neuronal L-Proline Transporter Dissertation zur Erlangung des Doktorgrades (Dr. rer. nat.) der Mathematisch-Naturwissenschaftlichen Fakultät der Rheinischen Friedrich-Wilhelms-Universität Bonn vorgelegt von Daniel Schulz aus Troisdorf Bonn 06.12.2011 Angefertigt mit Genehmigung der Mathematisch-Naturwissenschaftlichen Fakultät der Rheinischen Friedrich-Wilhelms-Universität Bonn 1. Gutachter: Prof. Dr. Eva Kostenis 2. Gutachter: Prof. Dr. Klaus Mohr Tag der Promotion: 26.03.12 Erscheinungsjahr: 2012 Die vorliegende Arbeit wurde in der Zeit von April 2007 bis November 2011 am Institut für Pharmazeutische Biologie der Rheinischen Friedrich-Wilhelms Universität Bonn unter der Leitung von Frau Prof. Dr. rer. nat. Evi Kostenis durchgeführt. Abstract I Abstract The neuronal high affinity L-proline transporter (PROT) is a putative neurotransmitter transporter whose contribution to neurotransmission is still unknown. PROT is expressed exclusively in brain by subpopulations of glutamatergic neurons and is assumed to conduct the reuptake of L-proline, which is released upon depolarization. Since to date no specific high-affinity receptor for L-proline has been discovered, the amino acid has been suggested to play a role regulating glutamatergic neurotransmission. To uncover the in vivo modulatory function of PROT, a mouse strain lacking functional PROT was generated and confirmed. The analysis of these PROT-knockout mice provided new insights into the modulatory functional roles of this transporter. Biochemical alterations within the central nervous system of PROT lacking mice were identified. Thus, PROT-deficient mice exhibit increased expression levels of N-methyl-D-aspartic acid (NMDA), α-amino-3-hydroxy-5 methylisoxazolepropionic acid (AMPA) and kainate (KA) receptor subunits.
    [Show full text]
  • Functional Kainate-Selective Glutamate Receptors in Cultured Hippocampal Neurons (Excitatory Amino Acid Receptors/Hippocampus) JUAN LERMA*, ANA V
    Proc. Natl. Acad. Sci. USA Vol. 90, pp. 11688-11692, December 1993 Neurobiology Functional kainate-selective glutamate receptors in cultured hippocampal neurons (excitatory amino acid receptors/hippocampus) JUAN LERMA*, ANA V. PATERNAIN, JosE R. NARANJO, AND BRITT MELLSTR6M Departamento de Plasticidad Neural, Instituto Cajal, Consejo Superior de Investigaciones Cientfficas, Avenida Doctor Arce 37, 28002-Madrid, Spain Communicated by Michael V. L. Bennett, September 15, 1993 ABSTRACT Glutamate mediates fast synaptic transmis- experiments, the regional distribution of high-affinity sion at the majority of excitatory synapses throughout the [3H]kainate binding sites does not match the AMPA receptor central nervous system by interacting with different types of distribution but corresponds well to the brain areas with high receptor channels. Cloning of glutamate receptors has pro- susceptibility to the neurotoxic actions of kainate (e.g., vided evidence for the existence of several structurally related hippocampal CA3 field) (13). However, patch-clamp record- subunit families, each composed of several members. It has ings from adult hippocampal neurons have revealed that been proposed that KA1 and KA2 and GluR-5, GluR-6, and native glutamate receptors are similar to the AMPA-type GluR-7 families represent subunit classes of high-affinity kain- recombinant glutamate receptors expressed from cDNA ate receptors and that in vivo different kainate receptor sub- clones but have failed so far to detect receptor channels ofthe types might be constructed from these subunits in heteromeric kainate type (14, 15). The only apparently high-affinity kain- assembly. However, despite some indications from autoradio- ate receptor channels have been found in the peripheral graphic studies and binding data in brain membranes, no nervous system (16, 17), although they are also activated by functional pure kainate receptors have so far been detected in AMPA.
    [Show full text]
  • Comparative Thermodynamics of Partial Agonist Binding to An
    COMPARATIVE THERMODYNAMICS OF PARTIAL AGONIST BINDING TO AN AMPA RECEPTOR BINDING DOMAIN A Dissertation Presented to the Faculty of the Graduate School of Cornell University In Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy by Madeline Martínez May 2015 © 2015 Madeline Martínez ALL RIGHTS RESERVED Comparative Thermodynamics of Partial Agonist Binding to an AMPA Receptor Binding Domain Madeline Martínez, Ph.D. Cornell University 2015 AMPA receptors, ligand-gated cation channels endogenously activated by glutamate, mediate the majority of rapid excitatory synaptic transmission in the vertebrate central nervous system and are crucial for information processing within neural networks. Their involvement in a variety of neuropathologies and injured states makes them important therapeutic targets, and understanding the forces that drive the interactions between the ligands and protein binding sites is a key element in the development and optimization of potential drug candidates. Calorimetric studies yield quantitative data on the thermodynamic forces that drive binding reactions. This information can help elucidate mechanisms of binding and characterize ligand- induced conformational changes, as well as reduce the potential unwanted effects in drug candidates. The studies presented here characterize the thermodynamics of binding of a series of 5’substituted willardiine analogues, partial agonists to the GluA2 LBD under several conditions. The moiety substitutions (F, Cl, I, H, and NO2) explore a range of electronegativity, pKa, radii, and h-bonding capability. Competitive binding of these ligands to glutamate-bound GluA2 LBD at different pH conditions demonstrates the effects of charge in the enthalpic and entropic components of the Gibb’s free energy of binding.
    [Show full text]
  • Agmatine Reverses Pain Induced by Inflammation, Neuropathy, and Spinal Cord Injury
    Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury Carolyn A. Fairbanks*†, Kristin L. Schreiber†, Kori L. Brewer‡, Chen-Guang Yu§, Laura S. Stone†, Kelley F. Kitto*†, H. Oanh Nguyen*, Brent M. Grocholski*, Don W. Shoeman*, Lois J. Kehl¶, Soundararajan Regunathanʈ, Donald J. Reisʈ, Robert P. Yezierski§, and George L. Wilcox*†** Departments of *Pharmacology and †Neuroscience and ¶Oral Science, University of Minnesota, Minneapolis, MN 55455; §University of Miami, The Miami Project, Miami, FL 33136; ʈDepartment of Neurology and Neuroscience, Weill–Cornell University Medical College, New York, NY 10021; and ‡East Carolina University School of Medicine, Department of Emergency Medicine, Greenville, NC 27858 Edited by Susan E. Leeman, Boston University School of Medicine, Boston, MA, and approved July 11, 2000 (received for review November 17, 1999) Antagonists of glutamate receptors of the N-methyl-D-aspartate geenan (CARRA), ketamine, dextromethorphan, ifenprodil, ␻ subclass (NMDAR) or inhibitors of nitric oxide synthase (NOS) aminoguanidine, N -nitro-L-arginine methyl ester (L-NAME), AG, prevent nervous system plasticity. Inflammatory and neuropathic NMDA, substance P (SP), memantine, and ␣-amino-3-hydroxy-5- pain rely on plasticity, presenting a clinical opportunity for the use methyl-4-isoxazolepropionic acid (AMPA)͞metabotropic agonist of NMDAR antagonists and NOS inhibitors in chronic pain. Agma- quisqualate (QUIS; Sigma); dynorphin (DYN; National Institute tine (AG), an endogenous neuromodulator present in brain and on Drug Abuse), SK&F 86466 (SmithKline Beecham), efaxoran spinal cord, has both NMDAR antagonist and NOS inhibitor activ- (Research Biochemicals), and moxonidine (Solvay Pharma). SP ities. We report here that AG, exogenously administered to ro- and moxonidine were dissolved in acidified saline; CARRA was dents, decreased hyperalgesia accompanying inflammation, nor- dissolved in PBS; and all the other drugs were dissolved in 0.9% malized the mechanical hypersensitivity (allodynia͞hyperalgesia) normal saline.
    [Show full text]